These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1804431)

  • 21. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
    Ozuysal S; Oztürk H; Bilgin T; Filiz G
    Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleolar organizer regions in differentiated preneoplastic and neoplastic endometrial lesions.
    Terlikowski S; Lenczewski A; Sulkowski S; Kulikowski M
    Gynecol Obstet Invest; 1999; 47(3):205-9. PubMed ID: 10087419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-Kit proto-oncogene expression in endometrial hyperplasia and endometrial cancer.
    Yilmaz E; Celik O; Simsek Y; Turkcuoglu I; Celik E; Gül M; Hascalik S; Aydin NE
    Arch Gynecol Obstet; 2012 Jul; 286(1):197-200. PubMed ID: 22392489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression and significance of heat shock protein 70, 90 in endometrial carcinomas].
    Bai XX; Chen YQ; Xin XY; Wang WD
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):38-40. PubMed ID: 15132902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleolar organizer regions as markers of endometrial proliferation: a study of normal, hyperplastic, and neoplastic tissue.
    Brustmann H; Riss P; Naudé S
    Hum Pathol; 1995 Jun; 26(6):664-7. PubMed ID: 7774898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proliferative activity in endometrial hyperplasia and adenocarcinoma.
    Terlikowski S; Lenczewski A; Famulski W; Sulkowska M; Kulikowski M
    Folia Histochem Cytobiol; 2001; 39(2):163-4. PubMed ID: 11374806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical study of Ki-67 and DNA topoisomerase II in human endometrium.
    Ito K; Sasano H; Yabuki N; Matsunaga G; Sato S; Kikuchi A; Yajima A; Nagura H
    Mod Pathol; 1997 Apr; 10(4):289-94. PubMed ID: 9110289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Silver staining of nucleolus organizer regions (NORs). Application to the study of nucleolar structure and value in pathology].
    Ploton D; Menager M; Lechki C; Jeannesson P; Visseaux B; Adnet JJ
    Ann Pathol; 1988; 8(3):248-52. PubMed ID: 2460107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive derailment of cell cycle regulators in endometrial carcinogenesis.
    Horrée N; van Diest PJ; van der Groep P; Sie-Go DM; Heintz AP
    J Clin Pathol; 2008 Jan; 61(1):36-42. PubMed ID: 17483252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial hyperplasia involving endometrial polyps: report of a series and discussion of the significance in an endometrial biopsy specimen.
    Kelly P; Dobbs SP; McCluggage WG
    BJOG; 2007 Aug; 114(8):944-50. PubMed ID: 17565613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of nucleolar organiser regions in aspiration smears of thyroid lesions.
    Gupta N; Brahmi UP; Kumar V; Rajwanshi A; Gupta SK
    Indian J Pathol Microbiol; 2005 Jul; 48(3):422-3. PubMed ID: 16761779
    [No Abstract]   [Full Text] [Related]  

  • 33. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
    Chen M; Lee JC; Lo S; Shen J
    Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nucleolar organizers and mitotic conditions in endometrial hyperplasia and carcinomaĭ].
    Ellinidi VN; Pozharisskii KM
    Vopr Onkol; 1999; 45(6):636-40. PubMed ID: 10703512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cyclin D1 in endometrial hyperplasia and endometrial carcinoma.
    Choudhury M; Bansal S
    Indian J Pathol Microbiol; 2007 Oct; 50(4):708-10. PubMed ID: 18306533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of nucleolar organizer regions (NORs) in ovarian epithelial tumors.
    Terlikowski S; Lenczewski A; Famulski W; Sulkowski S; Kulikowski M
    Folia Histochem Cytobiol; 2001; 39(2):161-2. PubMed ID: 11374805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleolar organizer regions in breast cytology material.
    Rath-Wolfson L; Hamel I; Halpern M; Klein B; Gal R
    Acta Cytol; 1995; 39(5):852-7. PubMed ID: 7571959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues.
    Brustmann H
    Pathol Res Pract; 2007; 203(2):65-72. PubMed ID: 17258405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endometrial atypical hyperplasia and subsequent diagnosis of endometrial cancer: a retrospective audit and literature review.
    Pennant S; Manek S; Kehoe S
    J Obstet Gynaecol; 2008 Aug; 28(6):632-3. PubMed ID: 19003662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.